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Materials and methods
Definition and calculation of platelet-associated aspirin clearance
The aspirin clearance in PRP (or PPP) was defined as the quantity of aspirin being cleared per minutes (pmol·min -1 ) (Eq.1), and the platelet-associated aspirin clearance was defined as the difference of aspirin clearance in PRP and aspirin clearance in PPP .
In equation 1, c is the concentration of aspirin added into PRP (or PPP), V is the total reaction volume, which is 270μL in our study, and t is the reaction time. The concentrations of salicylic acid and aspirin were determined by LC/MS. An aliquot of 40 μL PRP (or PPP) was transferred to a 1.5 mL centrifuge tube, to which was added 10 μL of internal standard (dissolved in acetonitrile). An aliquot (0.25 mL) of acetonitrile containing 0.1% formic acid was added and vortexed for the sample extraction. The sample was centrifuged at 18,000 rpm for 10min, and the resultant supernatant (0.2 mL) was transferred to another 1.5 mL centrifuge tube and further centrifuged at 20,000 rpm for 5min. The supernatant (0.15 mL) was transferred to an analytical vial, and 5 μL was injected directly into the LC-MS system. Analysis was carried out using a Shimadzu LCMS-2010A instrument (Shimadzu Technologies). The separation was performed on a Capcell-Pak stainless-steel column (C 18 , 5μm, 100mm×2.0mm I.D; Shimadzu). The mobile phase consisted of water (containing 0.05% formic acid) (A) and acetonitrile (B), which was programmed with a linear gradient system, began with 15% B for 0.5 minutes, increased from15% B to 50% B over a 5.5 min period, held at 50% B for 0.5 min, increased from 50% B to 90% B over a 0.5 min period, returned to 15% B over a 0.5 min period, and finally held at 15% B for another 4.5 min of equilibration. The flow rate was set at 0.2 mL/min. The mass spectrometer was operated in the negative ion mode in the m/z range of 136.95 (salicylic acid and aspirin) and 150.95 (3-methylsalicylic acid, internal standard).
In silico docking studies
The structures of ligands were built using Sybyl (Tripos), where energy minimization were set at 25,000,000 and 27,000, respectively. The population size was set at 300.
During the docking simulation, all atoms of the ligands were allowed to move while the protein structure was fixed. For each ligand, 100 LGA runs were conducted and followed by a cluster analysis with an RMSD tolerance of 2.0 Å. The conformations with the lowest docking energy were selected for further binding mode analysis.
Analysis of interacting data
Single drug inhibition
Observed values were expressed as percent of changes in light transmission. The inhibitory concentration-effect relationship was modeled with the sigmoid I max model (Eq.2):
(Equation 2) The S max was the maximum platelet aggregation of vehicle-treated PRP, while the back was defined as vehicle-treated PRP without AA challenge. The measured effects, E, was the percent of changes in light transmission at drug concentration. The maximal inhibitory effect (I max ) was equal to (S max -back). IC 50 represented the concentration producing 50% of I max and the slope of the concentration-effect relationship was given by γ.
Double drug interaction with the isobologram and URSA methods
Combination data were analyzed with the isobologram and the URSA methods. The URSA method applied to the double interactions between Pro, CA, or aspirin was shown in equation 3.
(Equation 3)
Where α was defined as an interaction parameter, and other parameters have been defined in the sigmoid I max model. If α was equal to zero, the interaction mode was 
